These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30079480)

  • 1. High levels of circulating cell-free DNA are a biomarker of active SLE.
    Xu Y; Song Y; Chang J; Zhou X; Qi Q; Tian X; Li M; Zeng X; Xu M; Zhang W; Cram DS; Liu J
    Eur J Clin Invest; 2018 Nov; 48(11):e13015. PubMed ID: 30079480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil extracellular traps-associated markers are elevated in patients with systemic lupus erythematosus.
    Jeremic I; Djuric O; Nikolic M; Vlajnic M; Nikolic A; Radojkovic D; Bonaci-Nikolic B
    Rheumatol Int; 2019 Nov; 39(11):1849-1857. PubMed ID: 31444555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical algorithm model based on cfDNA to predict SLE disease activity.
    Wang F; Liu YJ; Miao HB; Chen Z
    Lupus; 2024 Feb; 33(2):145-154. PubMed ID: 38183242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus.
    Zhang S; Lu X; Shu X; Tian X; Yang H; Yang W; Zhang Y; Wang G
    Intern Med; 2014; 53(24):2763-71. PubMed ID: 25500436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus.
    Brilland B; Bach-Bunner M; Gomes CN; Larochette V; Foucher E; Plaisance M; Saulnier P; Costedoat-Chalumeau N; Ghillani P; Belizna C; Delneste Y; Augusto JF; Jeannin P
    Front Immunol; 2021; 12():663192. PubMed ID: 34054830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients.
    Tug S; Helmig S; Menke J; Zahn D; Kubiak T; Schwarting A; Simon P
    Cell Immunol; 2014; 292(1-2):32-9. PubMed ID: 25243646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free DNA profiling in patients with lupus nephritis.
    Truszewska A; Wirkowska A; Gala K; Truszewski P; Krzemień-Ojak Ł; Perkowska-Ptasińska A; Mucha K; Pączek L; Foroncewicz B
    Lupus; 2020 Nov; 29(13):1759-1772. PubMed ID: 32924831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum free light chains for monitoring systemic lupus erythematosus activity].
    Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
    Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miRNA-21, miRNA-146a and plasma cell free DNA as novel biomarkers for assessing systemic lupus erythematosus activity.
    Ibrahim MRK; Waly NG; Moness H; Ahmed SS; Ibrahem R
    Mol Biol Rep; 2023 Dec; 50(12):10025-10036. PubMed ID: 37904010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
    Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
    Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis.
    Chuang HC; Chen YM; Hung WT; Li JP; Chen DY; Lan JL; Tan TH
    Oncotarget; 2016 Sep; 7(36):57593-57605. PubMed ID: 27557500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies.
    Bentow C; Lakos G; Martis P; Wahl E; Garcia M; Viñas O; Espinosa G; Cervera R; Sjöwall C; Carmona-Fernandes D; Santos MJ; Hanly JG; Mahler M
    Lupus; 2016 Jul; 25(8):864-72. PubMed ID: 27252263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
    Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
    Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
    Mora C; Medina-Rosas J; Santos AM; Jaimes DA; Arbeláez AM; Romero C; Cortes A; Londono J
    J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of plasma levels and immunoactivities of different forms of circulating-free DNA in systemic lupus erythematosus patients].
    Huang J; Li Z; Cheng L; Zhang P; Li X; Feng G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jul; 37(7):633-640. PubMed ID: 34140075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.